As you know, in the ‘008’ study high-dose ETC-1002 monotherapy lowered LDL by 30%, low-dose ETC-1002 monotherapy lowered LDL by 27%, and Zetia monotherapy lowered LDL by 21%.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.